| Name |
Format |
Description |
Link |
| Networking—A quintessential public health activity |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01-eng.pdf |
| Networking—A quintessential public health activity |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a01f-fra.pdf |
| Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02-eng.pdf |
| Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a02f-fra.pdf |
| Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03-eng.pdf |
| Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a03f-fra.pdf |
| Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04-eng.pdf |
| Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a04f-fra.pdf |
| Optimizing communication material to address vaccine hesitancy |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05-eng.pdf |
| Optimizing communication material to address vaccine hesitancy |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a05f-fra.pdf |
| Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06-eng.pdf |
| Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23a06f-fra.pdf |
| CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23-eng.pdf |
| CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/ccdrv46i23f-fra.pdf |
| Networking—A quintessential public health activity |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-1-networking-public-health.html |
| Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-2-canada-national-collaboration-centres-public-health.html |
| Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-3-naci-bivalent-factor-h-binding-protein-meningococcal-serogroup-b.html |
| Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-4-infection-prevention-control-lapse-ontario-2018.html |
| Optimizing communication material to address vaccine hesitancy |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-5-best-practices-addressing-vaccine-hesitancy.html |
| Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020/article-6-id-news.html |
| CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-2-3-february-6-2020.html |
| Networking—A quintessential public health activity |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-1-reseautage-sante-publique.html |
| Canada’s National Collaborating Centres: Facilitating evidence-informed decision-making in public health |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-2-centre-collaboration-nationale-sante-publique-canada.html |
| Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-3-ccni-proteine-liaison-bivalente-facteur-h-meningocoque-serogroupe-b.html |
| Infection prevention and control lapse involving medical equipment reprocessing at a family medicine clinic in Ottawa, Ontario, 2018 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-4-prevention-infections-manquements-mesures-controle-ontario-2018.html |
| Optimizing communication material to address vaccine hesitancy |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-5-pratiques-exemplaires-face-reticence-vaccination.html |
| Effective partnerships to address public health priorities; The impact of medical legal partnerships to improve health outcome; 2019 novel coronavirus: Outbreak update |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020/article-6-actualites-maladies-infectieuses.html |
| CCDR: Vol. 46 No. 2/3-Feb/Mar 2020: Public Health Network |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-2-3-6-fevrier-2020.html |